Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

NCT01530984 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to execute contract

Conditions

Prostate Cancer

Interventions

DRUG: Ipilimumab
DRUG: GM-CSF

Sponsor

Lawrence Fong

Collaborators

[object Object]
[object Object]